These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34507102)
21. Effect of cytidine(5')diphosphocholine (CDP-choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans. Lopez I; Coviella G; Agut J; Wurtman RJ J Neural Transm; 1986; 66(2):129-34. PubMed ID: 3746287 [TBL] [Abstract][Full Text] [Related]
22. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Morales AM; Lee B; Hellemann G; O'Neill J; London ED Drug Alcohol Depend; 2012 Oct; 125(3):230-8. PubMed ID: 22445480 [TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Caner B; Kafa MI; Bekar A; Kurt MA; Karli N; Cansev M; Ulus IH Neurol Res; 2012 Apr; 34(3):238-45. PubMed ID: 22449436 [TBL] [Abstract][Full Text] [Related]
24. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial. Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061 [TBL] [Abstract][Full Text] [Related]
25. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study. Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895 [TBL] [Abstract][Full Text] [Related]
26. Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Zorick T; Sugar CA; Hellemann G; Shoptaw S; London ED Drug Alcohol Depend; 2011 Nov; 118(2-3):500-3. PubMed ID: 21592681 [TBL] [Abstract][Full Text] [Related]
27. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2004; (2):CD000269. PubMed ID: 15106147 [TBL] [Abstract][Full Text] [Related]
28. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers. Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339 [TBL] [Abstract][Full Text] [Related]
29. The influence of cytidine on the endogenous pool of CDP-choline, CDP-ethanolamine, and CMP of the rat brain. Trovarelli G; Palmerini CA; Floridi A; Piccinin GL; Porcellati G Neurochem Res; 1984 Jan; 9(1):73-9. PubMed ID: 6717731 [TBL] [Abstract][Full Text] [Related]
30. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501 [TBL] [Abstract][Full Text] [Related]
31. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523 [TBL] [Abstract][Full Text] [Related]
32. Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report. Renshaw PF; Daniels S; Lundahl LH; Rogers V; Lukas SE Psychopharmacology (Berl); 1999 Feb; 142(2):132-8. PubMed ID: 10102764 [TBL] [Abstract][Full Text] [Related]
33. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534 [TBL] [Abstract][Full Text] [Related]
34. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Schwartz DL; Mitchell AD; Lahna DL; Luber HS; Huckans MS; Mitchell SH; Hoffman WF Neuroimage; 2010 May; 50(4):1392-401. PubMed ID: 20096794 [TBL] [Abstract][Full Text] [Related]
35. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Richardson UI; Watkins CJ; Pierre C; Ulus IH; Wurtman RJ Brain Res; 2003 May; 971(2):161-7. PubMed ID: 12706232 [TBL] [Abstract][Full Text] [Related]
36. CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischaemia. Grieb P; Gadamski R; Wojda R; Janisz M Folia Neuropathol; 2001; 39(3):141-5. PubMed ID: 11770124 [TBL] [Abstract][Full Text] [Related]
38. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder. He L; Yang BZ; Ma YJ; Wen L; Liu F; Zhang XJ; Liu TQ Front Cell Infect Microbiol; 2023; 13():1103919. PubMed ID: 36909722 [TBL] [Abstract][Full Text] [Related]
39. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750 [TBL] [Abstract][Full Text] [Related]